214 related articles for article (PubMed ID: 31710624)
1. The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitis.
Manthey CL; Moore BA; Chen Y; Loza MJ; Yao X; Liu H; Belkowski SM; Raymond-Parks H; Dunford PJ; Leon F; Towne JE; Plevy SE
PLoS One; 2019; 14(11):e0223918. PubMed ID: 31710624
[TBL] [Abstract][Full Text] [Related]
2. Anti-Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis.
Bloemendaal FM; Levin AD; Wildenberg ME; Koelink PJ; McRae BL; Salfeld J; Lum J; van der Neut Kolfschoten M; Claassens JW; Visser R; Bentlage A; D'Haens GRAM; Verbeek JS; Vidarsson G; van den Brink GR
Gastroenterology; 2017 Nov; 153(5):1351-1362.e4. PubMed ID: 28756234
[TBL] [Abstract][Full Text] [Related]
3. JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia.
Manthey CL; Johnson DL; Illig CR; Tuman RW; Zhou Z; Baker JF; Chaikin MA; Donatelli RR; Franks CF; Zeng L; Crysler C; Chen Y; Yurkow EJ; Boczon L; Meegalla SK; Wilson KJ; Wall MJ; Chen J; Ballentine SK; Ott H; Baumann C; Lawrence D; Tomczuk BE; Molloy CJ
Mol Cancer Ther; 2009 Nov; 8(11):3151-61. PubMed ID: 19887542
[TBL] [Abstract][Full Text] [Related]
4. An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma.
von Tresckow B; Morschhauser F; Ribrag V; Topp MS; Chien C; Seetharam S; Aquino R; Kotoulek S; de Boer CJ; Engert A
Clin Cancer Res; 2015 Apr; 21(8):1843-50. PubMed ID: 25628399
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-macrophage colony-stimulating factor elicits bone marrow-derived cells that promote efficient colonic mucosal healing.
Bernasconi E; Favre L; Maillard MH; Bachmann D; Pythoud C; Bouzourene H; Croze E; Velichko S; Parkinson J; Michetti P; Velin D
Inflamm Bowel Dis; 2010 Mar; 16(3):428-41. PubMed ID: 19639560
[TBL] [Abstract][Full Text] [Related]
6. Restoration of mucosal integrity and epithelial transport function by concomitant anti-TNFα treatment in chronic DSS-induced colitis.
Lenzen H; Qian J; Manns MP; Seidler U; Jörns A
J Mol Med (Berl); 2018 Aug; 96(8):831-843. PubMed ID: 29967942
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human granulocyte colony-stimulating factor reduces colonic epithelial cell apoptosis and ameliorates murine dextran sulfate sodium-induced colitis.
Kudo T; Matsumoto T; Nakamichi I; Yada S; Esaki M; Jo Y; Ohji Y; Yao T; Iida M
Scand J Gastroenterol; 2008; 43(6):689-97. PubMed ID: 18569986
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte Macrophage Colony-Stimulating Factor-Activated CD39
Weinhage T; Däbritz J; Brockhausen A; Wirth T; Brückner M; Belz M; Foell D; Varga G
Cell Mol Gastroenterol Hepatol; 2015 Jul; 1(4):433-449.e1. PubMed ID: 28210690
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the colony-stimulating-factor-1 receptor affects the resistance of lung cancer cells to cisplatin.
Pass HI; Lavilla C; Canino C; Goparaju C; Preiss J; Noreen S; Blandino G; Cioce M
Oncotarget; 2016 Aug; 7(35):56408-56421. PubMed ID: 27486763
[TBL] [Abstract][Full Text] [Related]
10. Oral pirfenidone protects against fibrosis by inhibiting fibroblast proliferation and TGF-β signaling in a murine colitis model.
Li G; Ren J; Hu Q; Deng Y; Chen G; Guo K; Li R; Li Y; Wu L; Wang G; Gu G; Li J
Biochem Pharmacol; 2016 Oct; 117():57-67. PubMed ID: 27498142
[TBL] [Abstract][Full Text] [Related]
11. The Bile Acid Receptor GPBAR1 Regulates the M1/M2 Phenotype of Intestinal Macrophages and Activation of GPBAR1 Rescues Mice from Murine Colitis.
Biagioli M; Carino A; Cipriani S; Francisci D; Marchianò S; Scarpelli P; Sorcini D; Zampella A; Fiorucci S
J Immunol; 2017 Jul; 199(2):718-733. PubMed ID: 28607110
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte macrophage colony-stimulating factor and the intestinal innate immune cell homeostasis in Crohn's disease.
Däbritz J
Am J Physiol Gastrointest Liver Physiol; 2014 Mar; 306(6):G455-65. PubMed ID: 24503766
[TBL] [Abstract][Full Text] [Related]
13. Mucosa repair mechanisms of Tong-Xie-Yao-Fang mediated by CRH-R2 in murine, dextran sulfate sodium-induced colitis.
Gong SS; Fan YH; Wang SY; Han QQ; Lv B; Xu Y; Chen X; He YE
World J Gastroenterol; 2018 Apr; 24(16):1766-1778. PubMed ID: 29713130
[TBL] [Abstract][Full Text] [Related]
14. Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease.
Kanai T; Watanabe M; Okazawa A; Sato T; Yamazaki M; Okamoto S; Ishii H; Totsuka T; Iiyama R; Okamoto R; Ikeda M; Kurimoto M; Takeda K; Akira S; Hibi T
Gastroenterology; 2001 Oct; 121(4):875-88. PubMed ID: 11606501
[TBL] [Abstract][Full Text] [Related]
15. FR167653, a p38 mitogen-activated protein kinase inhibitor, aggravates experimental colitis in mice.
Nishimura T; Andoh A; Nishida A; Shioya M; Koizumi Y; Tsujikawa T; Fujiyama Y
World J Gastroenterol; 2008 Oct; 14(38):5851-6. PubMed ID: 18855984
[TBL] [Abstract][Full Text] [Related]
16. Sodium chloride-enriched Diet Enhanced Inflammatory Cytokine Production and Exacerbated Experimental Colitis in Mice.
Monteleone I; Marafini I; Dinallo V; Di Fusco D; Troncone E; Zorzi F; Laudisi F; Monteleone G
J Crohns Colitis; 2017 Feb; 11(2):237-245. PubMed ID: 27473029
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming of monocytes by GM-CSF contributes to regulatory immune functions during intestinal inflammation.
Däbritz J; Weinhage T; Varga G; Wirth T; Walscheid K; Brockhausen A; Schwarzmaier D; Brückner M; Ross M; Bettenworth D; Roth J; Ehrchen JM; Foell D
J Immunol; 2015 Mar; 194(5):2424-38. PubMed ID: 25653427
[TBL] [Abstract][Full Text] [Related]
18. Increased production of retinoic acid by intestinal macrophages contributes to their inflammatory phenotype in patients with Crohn's disease.
Sanders TJ; McCarthy NE; Giles EM; Davidson KL; Haltalli ML; Hazell S; Lindsay JO; Stagg AJ
Gastroenterology; 2014 May; 146(5):1278-88.e1-2. PubMed ID: 24503130
[TBL] [Abstract][Full Text] [Related]
19. Leptin antagonist ameliorates chronic colitis in IL-10⁻/⁻ mice.
Singh UP; Singh NP; Guan H; Busbee B; Price RL; Taub DD; Mishra MK; Fayad R; Nagarkatti M; Nagarkatti PS
Immunobiology; 2013 Dec; 218(12):1439-51. PubMed ID: 23726523
[TBL] [Abstract][Full Text] [Related]
20. Novel anti-inflammatory agent 3-[(dodecylthiocarbonyl)-methyl]-glutarimide ameliorates murine models of inflammatory bowel disease.
Ichikawa N; Yamashita K; Funakoshi T; Ichihara S; Fukai M; Ogura M; Kobayashi N; Zaitsu M; Yoshida T; Shibasaki S; Koshizuka Y; Tsunetoshi Y; Sato M; Einama T; Ozaki M; Umezawa K; Suzuki T; Todo S
Inflamm Res; 2016 Mar; 65(3):245-60. PubMed ID: 26683259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
